Numerous studies have been conducted to investigate the mechanisms underlying the development of gestational diabetes, with a consistent finding indicating that pregnant women who develop this condition exhibit impaired responsiveness of pancreatic beta cells to increased insulin demands during pregnancy, coupled with reduced insulin sensitivity, resulting in varying degrees of hyperglycemia (10, 11). The gene discussed is INS; the disease is gestational diabetes.